| Adjusting the Outputs of a Classifier to New a Priori Probabilities: A Simple Procedure M Saerens, P Latinne, C Decaestecker Neural computation 14 (1), 21-41, 2002 | 453 | 2002 |
| Tracking of migrating cells under phase-contrast video microscopy with combined mean-shift processes O Debeir, P Van Ham, R Kiss, C Decaestecker IEEE transactions on medical imaging 24 (6), 697-711, 2005 | 382 | 2005 |
| Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients M Remmelink, R De Mendonça, N D’Haene, S De Clercq, C Verocq, ... Critical care 24, 1-10, 2020 | 319 | 2020 |
| Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis I Pastushenko, F Mauri, Y Song, F de Cock, B Meeusen, B Swedlund, ... Nature 589 (7842), 448-455, 2021 | 283 | 2021 |
| Can anti‐migratory drugs be screened in vitro? A review of 2D and 3D assays for the quantitative analysis of cell migration C Decaestecker, O Debeir, P Van Ham, R Kiss Medicinal research reviews 27 (2), 149-176, 2007 | 243 | 2007 |
| Identification of a Novel Cardenolide (2‘ ‘-Oxovoruscharin) from Calotropis procera and the Hemisynthesis of Novel Derivatives Displaying Potent in Vitro … E Van Quaquebeke, G Simon, A André, J Dewelle, ME Yazidi, F Bruyneel, ... Journal of medicinal chemistry 48 (3), 849-856, 2005 | 234 | 2005 |
| High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma (erratum) R Maréchal, P Demetter, N Nagy, A Berton, C Decaestecker, M Polus, ... British journal of cancer 103 (6), 930, 2010 | 228* | 2010 |
| Airway Biology and COPD-Reduced Epithelial Expression of Secretory Component in Small Airways Correlates with Airflow Obstruction in Chronic Obstructive Pulmonary Disease C Pilette, V Godding, R Kiss, M Delos, E Verbeken, C Decaestecker, ... American Journal of Respiratory and Critical Care Medicine 163 (1), 185-194, 2001 | 220* | 2001 |
| Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting N Nagy, H Legendre, O Engels, S André, H Kaltner, K Wasano, Y Zick, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 215 | 2003 |
| 3-Aryl-2-quinolone derivatives: synthesis and characterization of in vitro and in vivo antitumor effects with emphasis on a new therapeutical target connected with cell migration B Joseph, F Darro, A Béhard, B Lesur, F Collignon, C Decaestecker, ... Journal of medicinal chemistry 45 (12), 2543-2555, 2002 | 214 | 2002 |
| Digital holographic microscopy for the<?xpp qa?> three-dimensional dynamic analysis of in vitro <?xpp qa?> cancer cell migration F Dubois, C Yourassowsky, O Monnom, JC Legros, O Debeir, P Van Ham, ... Journal of biomedical optics 11 (5), 054032-054032-5, 2006 | 208 | 2006 |
| Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation AA Pozdzik, IJ Salmon, FD Debelle, C Decaestecker, C Van Den Branden, ... Kidney international 73 (5), 595-607, 2008 | 204 | 2008 |
| Galectin‐1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma S Rorive, N Belot, C Decaestecker, F Lefranc, L Gordower, S Micik, ... Glia 33 (3), 241-255, 2001 | 199 | 2001 |
| Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies N Sadeghi, N D'Haene, C Decaestecker, M Levivier, T Metens, C Maris, ... American journal of neuroradiology 29 (3), 476-482, 2008 | 195 | 2008 |
| Characterization of the activities of actin-affecting drugs on tumor cell migration C Hayot, O Debeir, P Van Ham, M Van Damme, R Kiss, C Decaestecker Toxicology and applied pharmacology 211 (1), 30-40, 2006 | 177 | 2006 |
| Limiting the number of trees in random forests P Latinne, O Debeir, C Decaestecker Multiple Classifier Systems: Second International Workshop, MCS 2001 …, 2001 | 162 | 2001 |
| Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme … B Le Calvé, M Rynkowski, M Le Mercier, C Bruyère, C Lonez, T Gras, ... Neoplasia 12 (9), 727-739, 2010 | 153 | 2010 |
| The determination of the levels of circulating galectin-1 and-3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy S Saussez, F Lorfevre, T Lequeux, G Laurent, G Chantrain, F Vertongen, ... Oral oncology 44 (1), 86-93, 2008 | 153 | 2008 |
| VEGFR1 and VEGFR2 involvement in extracellular galectin-1-and galectin-3-induced angiogenesis N D'Haene, S Sauvage, C Maris, I Adanja, M Le Mercier, C Decaestecker, ... PloS one 8 (6), e67029, 2013 | 150 | 2013 |
| Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers H Legendre, C Decaestecker, N Nagy, A Hendlisz, MP Schüring, I Salmon, ... Modern pathology 16 (5), 491-504, 2003 | 150 | 2003 |
